Drug Type Small molecule drug |
Synonyms asperlicin derivatives(Pfizer), CI-1015, PD-135308 |
Target |
Mechanism CCKB antagonists(Cholecystokinin B receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H39N3O4 |
InChIKeyYKZVFJYBIIABAI-VZHOGKRISA-N |
CAS Registry156672-01-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Preclinical | GB | 01 Jan 1998 | |
Pain | Discovery | US | - |